CD8 T Cell Cytotoxicity Assay
Corresponding Organization : Harvard University
Other organizations : Massachusetts General Hospital
Variable analysis
- Presence of tumor cells (B16^Nectin1 or ex vivo cultures) during co-culture with CD8 T cells
- Presence of wildtype B16^Necti1 or β2m^-/- B16^Nectin1 tumor cells
- Cell viability of co-cultured CD8 T cells and tumor cells, assessed using CellTiterGlo
- Fluorescent confluence loss of tumor cells, measured using a Celigo image cytometer
- CD8 T cells from TRP1^high Mice
- Stimulation of CD8 T cells with CD3/CD28 beads for 48 h
- Plating of target B16^Nectin1 or ex vivo cultures with 50 ng/mL IFNγ
- Various E:T (Effector:Target) ratios of CD8 T cells to tumor cells
- Wells containing the same number of CD8 T cells without tumor cells present
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!